Faculty of Physical Education and Sport Sciences, Tehran University, Tehran, Iran.
Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.
Amino Acids. 2024 Oct 13;56(1):60. doi: 10.1007/s00726-024-03420-7.
The gastrointestinal tract's epithelial barrier plays a crucial role in maintaining health. This study aims to investigate the impact of glutamine supplementation on intestinal permeability, considering its importance for immune function and nutrient absorption. The study adhered to the PRISMA protocol for systematic reviews and meta-analyses. A systematic search was performed in four databases (PubMed, Scopus, Web of Science, and Google Scholar) until April 2023 to identify clinical trials on glutamine supplementation and gastrointestinal permeability. Eligibility criteria included randomized placebo-controlled trials measuring gut permeability post-glutamine supplementation. Studies were included regardless of language or publication date. Data extraction involved study characteristics, intervention details, and outcomes. Quality assessment was performed using the Cochrane tool, and statistical analysis utilized mean differences and standard deviations with a random effects model. Subgroup analysis was conducted to explore heterogeneity. The systematic review and meta-analysis included 10 studies from 1998 to 2014 with 352 participants. A total of 216 patients were enrolled in the intervention group, and 212 in the control group. The mean participant age was 46.52 years. The participants had different types of diseases in terms of their health status. Overall, glutamine supplementation did not significantly affect intestinal permeability (WMD: -0.00, 95% CI -0.04, 0.03). Subgroup analysis showed a significant reduction in intestinal permeability with doses over 30g/day (WMD: -0.01, 95% CI -0.10, -0.08). The glutamine supplements were administered orally in all included studies. The meta-analysis demonstrated a significant reduction in intestinal permeability with glutamine supplementation exceeding 30 mg/day for durations of less than 2 weeks. Further investigations with varying dosages and patient populations are warranted to enhance understanding and recommendations regarding glutamine supplementation's effects on gut permeability.
胃肠道的上皮屏障在维持健康方面起着至关重要的作用。本研究旨在探讨谷氨酰胺补充对肠道通透性的影响,因为它对免疫功能和营养吸收很重要。该研究遵循 PRISMA 系统评价和荟萃分析协议。在 2023 年 4 月之前,我们在四个数据库(PubMed、Scopus、Web of Science 和 Google Scholar)中进行了系统搜索,以确定关于谷氨酰胺补充和胃肠道通透性的临床试验。纳入标准包括随机安慰剂对照试验,测量谷氨酰胺补充后肠道通透性。研究无论语言或发表日期如何均被纳入。数据提取包括研究特征、干预细节和结果。使用 Cochrane 工具进行质量评估,并使用随机效应模型分析均值差异和标准差。进行亚组分析以探索异质性。系统评价和荟萃分析纳入了 1998 年至 2014 年的 10 项研究,共有 352 名参与者。共有 216 名患者被纳入干预组,212 名患者被纳入对照组。参与者的平均年龄为 46.52 岁。根据健康状况,参与者患有不同类型的疾病。总体而言,谷氨酰胺补充对肠道通透性没有显著影响(WMD:-0.00,95%CI -0.04,0.03)。亚组分析显示,剂量超过 30g/天时,肠道通透性显著降低(WMD:-0.01,95%CI -0.10,-0.08)。所有纳入的研究均通过口服给予谷氨酰胺补充剂。荟萃分析表明,在 2 周内,每天补充超过 30mg 的谷氨酰胺可显著降低肠道通透性。需要进一步研究不同剂量和患者人群,以增强对谷氨酰胺补充对肠道通透性影响的理解和建议。